Probiotics and Infections in Children Attending Day Care Centres

Valio

Status and phase: Completed; Phase 3

Conditions: Gastrointestinal Diseases; Respiratory Tract Infections

Treatments: Other: Placebo; Dietary Supplement: Probiotic

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT01014676

Valio-69

Details and patient eligibility

About

The purpose of this study is to evaluate the effect of regular consumption of probiotic milk in preventing illnesses in Finnish children attending day care centres, and possible cost-benefits that could be associated with fewer illnesses.

Sex: All

Ages: 2 to 6 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 2 to 6 years in the beginning of the intervention
• Attendance at a day care centre participating in the study (5 days a week)

Exclusion criteria

• Milk allergy or lactose intolerance
• Congenital heart diseases that requires regular medication
• Malign diseases
• Cytostatic treatment
• Use of biological rheumatic medication
• Continuous microbial medication
• Regular use of oral corticosteroids (inhalable accepted)
• Diabetes
• Simultaneous participation in other clinical trials

Trial design

0 participants in 2 patient groups, including a placebo group

Probiotic milk

Active Comparator group

Treatment:

Dietary Supplement: Probiotic

Standard milk

Placebo Comparator group

Treatment:

Other: Placebo